8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Apr 12, 2022 · 4y ago · Accession 0001564590-22-014159
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Spyre Therapeutics, Inc.
- Ticker
- SYRE
- CIK
- 1636282
- Form type
- 8-K
- Filing date
- Apr 12, 2022
- Report date
- Apr 12, 2022
- Document
- agle-8k_20220412.htm
- Size
- 10.9 MB